Brief: Medexus Pharmaceuticals Reports Operating And Financial Results For The Three- And Six-Month Periods Ending September 30, 2020
Medexus Pharmaceuticals Inc MDP.V :
* MEDEXUS PHARMACEUTICALS REPORTS OPERATING AND FINANCIAL
RESULTS
FOR THE THREE- AND SIX-MONTH PERIODS ENDING SEPTEMBER 30, 2020
* MEDEXUS PHARMACEUTICALS INC - ACHIEVED REVENUE OF $23.6
MILLION
FOR THREE-MONTH PERIOD ENDED SEPTEMBER 30, 2020
Source text for Eikon: ID:nGNX3ZfsLR
Further company coverage: MDP.V
Recent news on Medexus Pharmaceuticals
See all newsCanada's Medexus Q4 revenue misses analyst expectations, net loss widens
Brief: Medexus Pharmaceuticals Q4 Revenue USD 24.652 Million Vs. IBES Estimate USD 25.6 Million
Canada Research Roundup: CAE, Medexus Pharmaceuticals, TCP Energy
Medexus Pharma Q2 revenue misses estimates
Brief: Medexus Pharmaceuticals Q2 Revenue USD 24.741 Million Vs. IBES Estimate USD 25.6 Million